Assistant Professor, Medicine, University of Wisconsin Medical School
Oncology
Dr. Noelle K. Loconte, MD
|
|
Give Review
Noelle Loconte is an expert in the field of Oncology. He attended University of Illinois College of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Noelle K. Loconte is a published doctor. He published 35 publications, including: 'A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors.' Noelle K. Loconte, MD is registered with Medicare.
Publications
- A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid Tumors.
- Mailed invitations for coloRectal screening are effective in increasing screening participation in uninsured adults with faecal immunochemical testing: the preferred s...
- Determining breast Cancer axillary surgery within the surveillance epidemiology and end results-Medicare database.
- Adjuvant Chemotherapy for Stage II Right-Sided and Left-Sided Colon Cancer: Analysis of SEER-Medicare Data.
- Characterizing the psychological distress response before and after a Cancer diagnosis.
- Patient Demographic and Tumor Characteristics Influencing Oncologist Follow-Up Frequency in Older Breast Cancer Survivors.
- Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on Clinical Management of the Axilla in Older Breast Cancer Patients: A SEER-Medicare An...
- Predictors of Short-Term Postoperative Survival After Elective Colectomy in Colon Cancer Patients ?80 Years of Age.
- A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract Cancer: a Wisconsin oncology network study.
- Surgical treatment of colon Cancer in patients aged 80 years and older : Analysis of 31,574 patients in the SEER-Medicare database.
- Cancer Screening of Long-Term Cancer Survivors.
- Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features.
- A Pilot Phase II Study of Valproic Acid for Treatment of Low-Grade Neuroendocrine Carcinoma.
- Phase I Study of Sunitinib and Erlotinib in Advanced Nonsquamous Non-small Cell Lung Cancer.
- A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate Cancer.
- Optimizing surgical care of colon Cancer in the older adult population.
- Increasing Disparity in Colorectal Cancer Incidence and Mortality Among African Americans and Whites: A State's Experience.
- A preclinical and clinical study of lithium in low-grade neuroendocrine Tumors.
- Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid Tumors: phase I study results.
- Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary Cancer: a phase II Conso...
- A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal Cancer.
- Readmission after colectomy for Cancer predicts one-year mortality.
- Standardized note template improves screening of firearm access and driving among veterans with dementia.
- Assessment of guilt and shame in patients with non-small-cell lung Cancer compared with patients with breast and prostate Cancer.
- Guillain-Barré syndrome after treatment with sunitinib malate?
- Disparities in Cancer care for older adults.
- Engaging health systems to increase colorectal Cancer screening: community-clinical outreach in underserved areas of Wisconsin.
- A phase I study of an oral simulated FOLFOX with high dose capecitabine.
- A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced Cancer.
- Perceived stigma, self-blame, and adjustment among lung, breast and prostate Cancer patients.
- Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy.
- Persistence in breast Cancer disparities between African Americans and whites in Wisconsin.
- Mortality by stage for right- versus left-sided colon Cancer: analysis of surveillance, epidemiology, and end results--Medicare data.
- A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid Tumors.
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Geriatric Medicine
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- American Republic
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Preferred Plus POS
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Group Health Cooperative
- Choice Care PPO
- Medicare MCR
- Pekin Insurance
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Wisconsin -
Oregon Health & Science University -
University of Illinois College of Medicine
Hospital
-
University of Wisconsin Hospital and Clinics
Drug Facts
| NPI NUMBER | 1972568269 | |
| NPPES Provider LastName | LOCONTE | |
| NPPES Provider FirstName | NOELLE | |
| NPPES Provider ZIPCode | 537920001 | |
| NPPES Provider State | WI | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 340.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 74.0 | |
| Percent Opioid Claims | 21.76 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1972568269 |
| Last Name Of The Provider | LOCONTE |
| First Name Of The Provider | NOELLE |
| View All |
Similar Doctors
|
|
Dr. Alexis M. Eastman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Siebers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher J. Hildebrand, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark A. Sager, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John E. Blanchard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John O. Wills, MD |
|
|
Dr. Wendy L. Adams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Alfich, MD |
|
|
Dr. Robert B. Hegeman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard H. Bailey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kari B. Wisinski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glenn Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dustin A. Deming, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James F. Cleary, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Adnan A. Zaidi, MD |